Chronic alcoholism exerts toxic effects on the male reproductive system(Reference Anderson, Willis and Oswald1). Chronic and persistent alcohol use is known to induce sexual dysfunction(Reference Arackal and Benegal2). Prolonged alcohol abuse in men can cause testosterone deficiency and testicular atrophy, which can lead to impotence, sterility and feminisation(Reference Bannister and Losowsky3). Alcohol is well documented as a direct testicular toxin(Reference Vanthiel, Gavaler and Lester4) and can cause significant deterioration in sperm concentration, motility and morphology in alcoholic men(Reference Ylikahri, Huttunen and Harkonen5, Reference Mendelson, Ellingboe and Mello6). Numerous experimental data indicate that free radical mechanisms contribute to ethanol-induced testicular alterations(Reference Grattagliano, Vendemiale and Errico7). Animal studies have indicated that depletion in antioxidant status occurs as a result of oxidative stress due to excess alcohol intake(Reference Aitken and Roman8, Reference Schlorff, Husain and Somani9).
Ascorbic acid or l-ascorbate is a major water-soluble chain-breaking antioxidant that is able to neutralise free radicals. It is essential for the maintenance of the structural and functional integrity of testes(Reference Chinoy10). Ascorbic acid plays a significant role in semen integrity and fertility, both in human subjects(Reference Agarwal, Prabakaran and Said11, Reference Eskenazi, Kidd and Marks12) and experimental animals(Reference Sonmez, Turk and Yuce13), and contributes to about 65 % of the total antioxidant capacity of seminal plasma found intracellularly and extracellularly(Reference Makker, Agarwal and Sharma14). Guinea pigs maintained on a high-ascorbic acid diet showed reduction in ethanol-induced toxicity as compared with low ascorbic acid-supplemented animals. High dietary levels of ascorbic acid were found to be protective against hepatic steatosis, necrosis and elevated levels of serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase in guinea pigs caused by chronic ethanol consumption(Reference Susick, Abrams and Zurawski15).
Although significant progress has been made in understanding the pathogenesis of alcoholic testicular damage, treatment options are limited. At present, abstention from taking alcohol seems to be the only effective therapy adopted to bring down the toxic effects of alcohol. Hence, an effective and economic way to overcome the alterations induced by chronic alcohol abuse has become important. Earlier studies conducted in our laboratory have shown that ascorbic acid mitigates alcohol-induced hepatotoxicity(Reference Abhilash, Harikrishnan and Indira16). Hence, we extended our studies to analyse the impact of ascorbic acid on ethanol-induced reproductive toxicity. Animal models have been developed to study chronic alcohol abuse by the oral administration of alcohol. Like human beings, guinea pigs are unable to synthesise ascorbic acid due to the lack of a key biosynthetic enzyme, l-gulonolactone oxidase(Reference Nishikimi, Kawai and Yagi17). The present study investigated the effect of ascorbic acid supplementation during abstention in chronic alcoholic guinea pigs on reproductive toxicity and compared it with those animals in abstention.
Materials and methods
Experimental animals
Sexually matured male guinea pigs (Cavia porcellus) of Hartley strain, weighing between 400 and 450 g, procured from Small animals breeding station, Mannuthy, Thrissur, Kerala, India, were used. The animals were maintained under standard animal husbandry conditions. The animals were housed in polypropylene cages, kept under controlled conditions of temperature of 28 ± 2°C, 45–60 % relative humidity and exposed to a 12 h dark–12 h light cycle. Male guinea pigs were fed with guinea pig feed (Sai Feeds) and water was given ad libitum. The study protocol was approved by the institutional animal ethics committee (IAEC-KU-6/09-10-BC-MI (21)). Animals were handled using the laboratory animal welfare guidelines(Reference Hume18). Absolute alcohol was purchased from M/s Merck Limited. Ethanol diluted with distilled water (1:1, v/v) was given by oral administration. Ascorbic acid was purchased from M/s SRL Limited. Ascorbic acid was freshly dissolved in distilled water during treatment and given orally by gastric tube.
Experimental design
Phase I: Dose-dependent studies
Dose-dependent studies were carried out to find the optimum dose of ascorbic acid to be given for regression of alcohol-induced testicular toxicity.
Groups
A total of forty-two guinea pigs were first grouped into two and maintained for 90 d as follows: group 1: control (C1) (n 12) and group 2: ethanol treated (4 g/kg body weight (b.wt.)/d) (E) (n 30). The dose of alcohol was selected from previous studies(Reference Green, Watts and Kobus19). Animals in the control group were given glucose solution equivalent to the energy supplied by ethanol (isoenergetic). Ethanol administration was stopped after 90 d, and six animals in the ethanol-treated group and the control group were killed after overnight fasting and the testis and the blood were collected for biochemical analysis. The animals in the ethanol-treated group were further divided into four groups of six guinea pigs each to which ascorbic acid of different doses was supplemented: E+AA (1 mg/100 g b.wt.) (n 6), E+AA (10 mg/100 g b.wt.) (n 6), E+AA (25 mg/100 g b.wt.) (n 6) and E+AA (50 mg/100 g b.wt.) (n 6). The remaining animals in the control group (C2) (n 6) were fed with a normal diet. The period of regression was 30 d. Previous studies(Reference Abhilash, Harikrishnan and Indira16) in our laboratory have shown that administration of ethanol for 90 d, at a dose of 4 g/kg b.wt., is ideal to create a chronic alcohol model, and reversal for 30 d using ascorbic acid has been effective in protection against alcohol-induced hepatotoxicity. Hence, the duration of the study was 90 d for toxicity induction and 30 d for reversal. The experimental design is schematically represented in Fig. 1.
At the end of the experimental period, animals were fasted overnight, anaesthetised by ketamine hydrochloride and then killed. The testes were dissected out and cleaned with ice-cold PBS, blotted dry and immediately transferred to ice-cold containers for biochemical and sperm characteristic analysis. Blood was collected for various biochemical analyses.
Phase II
A total of thirty-six guinea pigs were first grouped into two: group 1: control (C) (n 18) and group 2: ethanol (4 g/kg b.wt./d) treated (E) (n 18). Alcohol at a dose of 4 g/kg b.wt. was given for a period of 90 d. The control group was given isoenergetic glucose solution. Blood was collected weekly from the ear of guinea pigs, and the weekly progression and regression of ethanol toxicity was assessed by assaying the activity of the toxicity marker, γ-glutamyl transpeptidase (GGT), in serum. After 90 d, ethanol administration was stopped and six animals each from the control and the ethanol-treated groups were killed after overnight fasting. The control group was used to evaluate whether the toxicity was induced after 90 d of alcohol administration in the ethanol-treated group by the assay of liver function markers alanine aminotransferase, aspartate aminotransferase and GGT in serum. All other parameters were analysed only in the ethanol-treated group. The blood was collected and the testis and accessory reproductive organs, epididymis and seminal vesicle, were dissected from the ethanol-treated group for various biochemical analysis. The remaining animals in the control group were maintained as control (C) (n 6) and ascorbic acid-treated groups (C+AA) (25 mg/100 g b.wt.) (n 6) and the remaining animals in the ethanol-treated group were further divided into two groups as the ascorbic acid-treated groups (E+AA) (25 mg/100 g b.wt) (n 6) and the ethanol abstention group (EAG) (n 6). The experimental design is schematically represented in Fig. 2.
The dose of ascorbic acid was selected from phase I studies. The period of regression was 30 d. At the end of the experimental period (90+30 d), animals were fasted overnight, anaesthetised by ketamine hydrochloride and then killed. The testis, epididymis and seminal vesicle were removed and their absolute and relative b.wt. (relative b.wt. = organ weight/final b.wt. × 100) were determined. The testis was dissected out and cleaned with ice-cold PBS, blotted dry and immediately transferred to ice-cold containers for various biochemical evaluations. Blood was collected in clean, dry test-tubes, and allowed to clot at room temperature. The clear serum was removed after centrifugation and used immediately for the assay of alanine aminotransferase, aspartate aminotransferase and GGT and stored at − 20°C until the assay of hormones. For plasma, blood was collected in heparinised tubes, centrifuged at 3000 g for 10 min and stored at − 20°C for HPLC analysis of ascorbic acid.
Methods
Semen characteristics
Seminal content of epididymis was obtained by cutting the cauda epididymis using surgical blades and squeezed onto a sterile clean watch glass. This content was diluted ten times with 2·9 % sodium citrate dehydrate solution and thoroughly mixed to estimate the percentage progressive motility and sperm concentration(20). One drop of the suspension was smeared on a glass slide and stained by eosin–nigrosin stain to determine the percentage of sperm cell viability and morphological abnormalities(20).
Biochemical parameters
Activity of alanine aminotransferase, aspartate aminotransferase(Reference Reitman and Frankel21) and GGT(Reference Szaz22) in serum was assayed. Succinate dehydrogenase (SDH) activity(Reference Ohkawa, Ohishi and Yagi23) and adenosine triphosphatase (ATPase) activity in testes(Reference Patterson, Lazarow and Glick24) were estimated. Activity of sorbitol dehydrogenase (SORD) in seminal vesicle(Reference Roe and Kuether25) and the seminal fructose content(Reference Beatty, Basinger and Dully26) were determined. Glutathione (GSH) content(Reference Quinn and White27) and ascorbic acid levels in testes(Reference Wootton28) were measured. Malondialdehyde (MDA) levels(Reference Karvonen and Malm29) and total protein in testes(Reference Lowry, Rosebrough and Farr30) were estimated.
Assay of serum testosterone, luteinising hormone and follicle-stimulating hormone
Serum testosterone was assayed using a solid-phase RIA kit obtained from the Diagnostic Products Corporation. The sensitivity of the testosterone assay was 4 pg/l. Follicle-stimulating hormone (FSH) and luteinising hormone (LH) were measured using an electrochemiluminescence immunoassay using a Boehringer Manheim Elecsys 2010 Immuno analyser (Roche Diagnostics). The detection limits were 0·10 mIU/ml for FSH and LH.
Determination of ascorbic acid in plasma by HPLC
One part plasma with four parts of 6 % metaphosphoric acid were mixed in a polypropylene storage vial. The vial contents were vortexed and centrifuged at 10 000 g for 15 min at 4°C and the supernatant was used for analysis. HPLC analysis was done by the Shimadzu Prominence SCL-20AHT (Shimadzu) system and the separation of ascorbic acid was done by isocratic gradient elution using a Luna 5S NH2 100A column (Phenomenex). The length of the column was 250 mm × 4·6 mm and the particle size was 5 μm. The mobile phase was HPLC-grade water (eluent A) and methanol (eluent B) in a 1:1 ratio, the total flow rate was 1·0 ml per min and the time of analysis was 15 min. The detector's wavelengths were set at 268 nm. The injection volume was 20 μl and the temperature of the column was thermostated at 40°C.
Assay of 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase
Assay of 3β-hydroxysteroid dehydrogenase (3β-HSD) was carried out according to the colorimetric assay of Shivanandappa & Venkatesh(Reference Shivanandappa and Venkatesh31). Tissue was homogenised in 0·1 m-Tris–HCl and centrifuged at 12 000 g at 40°C. To 0·05 ml homogenate, 1 ml NAD, 1 ml dehydroepiandrosterone (DHEA) and 0·9 ml water were added and incubated for 1 h at 37°C. The reaction was stopped using 2 ml phthalate buffer. The turbidity was removed by centrifugation at 1000 g for 20 min. Supernatant was read at 490 nm. Activity of 17β-hydroxysteroid dehydrogenase (17β-HSD) was measured according to the method of Jarbak et al. (Reference Jarbak, Colowick and Kaplan32). The testicular supernatant (1 ml) was mixed with 440 μm of sodium pyrophosphate buffer (pH 10·2), 25 mg crystalline bovine serum albumin and 0·3 μm of testosterone. The total volume was made up to 3 ml. Enzyme activity was measured after the addition of 1·1 μm-NADP to the incubation mixtures in a spectrophotometer at 340 nm. For a detailed description of the procedures, see Supplementary material (available online).
Statistical analysis
Data are presented as means with their standard errors. The degree of significance was set at P< 0·05. One-way ANOVA and post hoc Tukey-honestly significant difference test were used to determine the differences among the groups. All the analyses were carried out using the SPSS/PC (version 17.0; SPSS) software package program.
Results
Phase I
The dose-dependent studies showed (Table 1) that animals supplemented with ascorbic acid at a dose of 25 mg/100 g b.wt. and 50 mg/100 g b.wt. showed significant (P< 0·001) revival in sperm count and a decrease in elevated testicular MDA levels induced by ethanol administration, as compared with the control. The maximum effect was shown by the group supplemented with 25 mg/100 g b.wt. ascorbic acid. The low dose groups (1 and 10 mg/100 g b.wt. ascorbic acid) did not significantly restore the sperm count and testicular MDA levels. The activity of the toxicity marker, GGT, in serum, which was increased significantly (P< 0·001) in the alcohol-ingested group, was reduced significantly (P< 0·001) in groups supplemented with 25 and 50 mg/100 g b.wt. of ascorbic acid and maximum recovery was shown by the group supplemented with 25 mg/100 g b.wt. of ascorbic acid.
C1, control group maintained for first 90 d; E, ethanol-treated group; C2, control group maintained for last 30 d; E+AA (1 mg/100 g b.wt.), 1 mg/100 g body weight ascorbic acid-supplemented group; E+AA (10 mg/100 g b.wt.), 10 mg/100 g body weight ascorbic acid-supplemented group; E+AA (25 mg/100 g b.wt.), 25 mg/100 g body weight ascorbic acid-supplemented group; E+AA (50 mg/100 g b.wt.), 50 mg/100 g body weight ascorbic acid-supplemented group.
a,b,c,dMean values within a column with unlike superscript letters were significantly different (P< 0·05).
Phase II
The liver function markers alanine aminotransferase, aspartate aminotransferase and GGT (Table 2) in serum increased significantly (P< 0·001) in the ethanol-treated group when compared with the control.
C, control group; E, ethanol-treated group.
a,bMean values within a column with unlike superscript letters were significantly different (P< 0·05).
The b.wt. of guinea pigs (Table 3) decreased significantly (P< 0·05) in the alcohol-administered group when compared with the control. The b.wt. of both the E+AA and EAG groups increased significantly (P< 0·01). However, the change in b.wt. in the ascorbic acid-supplemented group (P< 0·001) was significantly higher than in the EAG group.
C, control group; C+AA, control+ascorbic acid group; E, ethanol-treated group; EAG, ethanol abstention group; E+AA, ascorbic acid-supplemented group; b.wt., body weight.
a,b,c,dMean values within a row with unlike superscript letters were significantly different (P< 0·05).
The relative weight of testes and epididymis (Table 3) decreased significantly (P< 0·05) in the ethanol-administered group, as compared with the control. The relative weight of these organs increased on ascorbic acid administration. The abstention group also showed an increase in relative testicular weight but was less significant when compared with the ascorbic acid-supplemented group. However, the abstention group showed an increase in relative epididymal weight similar to the ascorbic acid-supplemented group. No significant change was observed in relative organ weights of the seminal vesicle.
GGT in serum during the treatment period (Fig. 3) showed a gradual increase in activity upon administration of ethanol. Both ascorbic acid supplementation and abstention significantly (P< 0·05) decreased the activity of GGT. However, a faster recovery was observed in the E+AA group than with abstention.
Sperm parameters, like percentage sperm motility, sperm count and viability (Table 4), decreased significantly (P< 0·001) in the ethanol-treated guinea pigs. The percentage of abnormal sperms with marked morphological defects, like headless sperm, double-headed sperm, tailless sperm, looped tail and coiled tail sperms, increased significantly in the ethanol-treated group, as compared with the control. The sperm parameters were restored on ascorbic acid administration. Abstention was also able to reverse the sperm parameters, but was less significant when compared with the ascorbic acid-treated group.
C, control group; C+AA, control+ascorbic acid group; E, ethanol-treated group; EAG, ethanol abstention group; E+AA, ascorbic acid-supplemented group.
a,b,c,dMean values within a column with unlike superscript letters were significantly different (P< 0·05).
The lipid peroxidation product, MDA (Table 5), increased significantly (P< 0·05) in the alcohol-ingested group when compared with the control, which was reduced on ascorbic acid supplementation. The MDA concentration also showed a decline in the abstention group, but was less pronounced when compared with the ascorbic acid-supplemented group.
C, control group; C+AA, control+ascorbic acid group; E, ethanol-treated group; EAG, ethanol abstention group; E+AA, ascorbic acid-supplemented group.
a,b,c,dMean values within a row with unlike superscript letters were significantly different (P< 0·05).
The concentrations of testicular GSH content and ascorbic acid in testes (Table 5) and plasma (Fig. 4) were reduced significantly (P< 0·001) in the ethanol-loaded group, which were restored to near-normal levels on ascorbic acid administration. Abstention could also increase the levels of GSH and ascorbic acid, but to a lesser extent when compared with the ascorbic acid-supplemented group.
Serum testosterone, LH and FSH levels (Table 6) were significantly reduced (P< 0·05) in the alcohol-administered group, but were elevated on ascorbic acid supplementation. Abstention did not significantly improve the testosterone concentration and gonadotropin levels, as compared with the ascorbic acid-treated group.
C, control group; C+AA, control+ascorbic acid group; E, ethanol-treated group; EAG, ethanol abstention group; E+AA, ascorbic acid-supplemented group.
a,b,c,d,eMean values within a column with unlike superscript letters were significantly different (P< 0·05).
The activities of key steroidogenic enzymes, 3β-HSD and 17β-HSD (Table 7), were reduced significantly (P< 0·05) in the ethanol-administered group, as compared with the control. The activities of these enzymes increased significantly (P< 0·05) in the ascorbic acid-administered group and with abstention. The increase in the activities was more pronounced in the ascorbic acid-supplemented group when compared with abstention.
C, control; E, ethanol-treated group; C+AA, control+ascorbic acid-treated group; EAG, ethanol abstention group; E+AA, ascorbic acid-supplemented group.
a,b,c,dMean values within a row with unlike superscript letters were significantly different (P< 0·05).
* μg of fructose liberated/min at 37°C.
† Change in absorbance of 0·001/min at 340 nm.
The concentration of fructose (Table 7) in seminal plasma and activity of SORD in seminal vesicle were reduced significantly (P< 0·05) in the alcohol-administered group, as compared with the control. Ascorbic acid supplementation significantly (P< 0·05) increased their concentration compared with the abstention group.
The SDH and ATPase activity (Table 7) in testes dropped significantly (P< 0·05) in the alcohol-fed group when compared with the control. Their activities were brought back to near-normal level by the administration of ascorbic acid. Abstention also increased their activities, but was less significant compared with the ascorbic acid-fed group.
Discussion
Earlier reports(Reference Makker, Agarwal and Sharma14) have implicated the role of reactive oxygen species-mediated oxidative stress in the pathophysiology of alcohol-mediated reproductive toxicity. Numerous studies are available regarding the effect of ascorbic acid on alcohol-induced hepatotoxicity. However, very less information is available regarding the effect of ascorbic acid in alcohol-mediated testicular dysfunctions in scorbutic animal models. Ascorbic acid is one of the important and essential vitamins for human health. It functions physiologically as a water-soluble antioxidant by virtue of its high reducing power and acts as a cofactor for enzymes involved in the biosynthesis of collagen, carnitine and neurotransmitters, and quenches a variety of reactive oxygen species and reactive nitrogen species in the aqueous environment(33). Several conditions, such as alcoholism, stress, smoking, infections and various pathological conditions, which increase oxidative stress, deplete the ascorbic acid reserves in the body and demand higher doses of ascorbic acid supplementation(Reference Naidu34). The new average daily intake level for human subjects that is sufficient to meet the nutritional requirement of ascorbic acid or RDA for adults (>19 years) are 90 mg/d for men and 75 mg/d for women(Reference Frei and Trabe35). We initially carried out a dose–response study to find the effective dose of ascorbic acid required to reduce alcohol-induced testicular alteration in guinea pigs. Further investigations were done using the selected dose to analyse the impact of ascorbic acid supplementation on ethanol-induced reproductive toxicity in male guinea pigs and also to compare it with abstention.
The dose–response study revealed that a dose of 25 mg/100 g b.wt. of ascorbic acid showed the maximum effect in regression of alcohol-induced testicular toxicity by bringing down MDA levels and restoring the sperm count to near-normal levels. The activity of the toxicity marker, GGT, in serum was also significantly reduced and was brought to a near-normal level by supplementing 25 mg/100 g b.wt of ascorbic acid. Hence, this dose was non-toxic and was selected for further studies.
The progression and regression of alcohol-induced toxicity were evaluated by the assay of GGT in the serum, a marker for ethanol-induced toxicity on a weekly basis. Both ascorbic acid supplementation and abstention could reduce the toxicity induced by alcohol, but a faster recovery was recorded in the case of ascorbic acid supplementation, indicating the role of ascorbic acid as a therapeutic agent to reduce alcohol-induced damage. This reduction in toxicity was also reflected in body weight gain and an increased relative organ weight of testes in the ascorbic acid-supplemented group, as compared with abstention.
The testicular MDA levels were elevated and levels of non-enzymatic antioxidants like GSH in testes and ascorbic acid levels in testes and plasma were diminished in alcohol-administered animals, suggesting a state of oxidative stress in testes. GSH and ascorbic acid are lines of defence against oxidative damage and facilitate protection against ethanol-induced reactive oxygen species production. Depletion in antioxidants enhances oxidative stress in testes. This is in agreement with the study of Grattagliano et al. (Reference Grattagliano, Vendemiale and Errico7). Ascorbic acid supplementation was able to reduce the oxidative stress induced by chronic alcoholic intake by reducing the enhanced levels of MDA and by alleviating the depleted levels of GSH and ascorbic acid. Abstention could also lower oxidative stress, but to a smaller extent when compared with the ascorbic acid-administered group. The observation in the present study is in line with our(Reference Abhilash, Harikrishnan and Indira36) previous reports that supplementation of ascorbic acid reduced the depletion of GSH in the liver caused by the administration of ethanol. Hence, reduction in oxidative stress caused by alcohol may be one of the mechanisms of ascorbic acid to provide a protective effect against alcohol-induced toxicity.
Ethanol administration reduced circulating testosterone levels. This may be due to the decreased activities of the major steroidogenic enzymes, 3β-HSD and 17β-HSD, involved in testosterone biosynthesis in the ethanol-treated group. This is in accord with the studies of Maneesh et al. (Reference Maneesh, Jayalekshmi and Dutta37). The reduction in testosterone levels can also be attributed to a suppressed hypothalamic–pituitary–gonadal axis, as there was a significant decrease in circulating LH and FSH levels in ethanol-administered animals. This is in agreement with the observation of Salonen & Huhtaniemi(Reference Salonen and Huhtaniemi38). Ascorbic acid plays a key role in the synthesis of testosterone(Reference Biswas, Chaudhuri and Sarkar39), and ascorbic acid deficiency can affect testosterone synthesis in testes. In the present study, ascorbic acid supplementation increased the activities of the steroidogenic enzymes, 3β-HSD and 17β-HSD, and also elevated serum testosterone, LH and FSH levels. However, abstention could not significantly restore the steroidogenic enzyme activities and circulating testosterone, LH and FSH levels, as compared with the ascorbic acid-supplemented group.
The quality of semen in ethanol-treated groups deteriorated as sperm parameters like percentage motility, viability and count were significantly reduced. There was a significant impairment in the morphology of sperm, as the percentage of abnormal sperms increased on excessive alcohol consumption. A low testosterone concentration may be responsible for the adverse effects of ethanol on sperm parameters, as a high level of testosterone in testes is critically required for normal spermatogenesis, development and maintenance of sperm morphology and normal physiology of seminiferous tubules(Reference Sharpe, Donachie and Cooper40, Reference Sharpe, Maddocks and Millar41). The diminution of sperm parameters was restored by ascorbic acid supplementation. The findings are in agreement with studies of Ganaraja et al. (Reference Ganaraja, D'souza and Vijayalekshmi42). Abstention from alcohol was also able to revive the sperm parameters. However, the reversal was more pronounced in the ascorbic acid-supplemented group than with abstention.
Fructose is a main source of energy for sperm motility. Fructose is produced from sorbitol by the coordinated function of SORD and serves as an energy source for spermatozoa(Reference Frenkel, Peterson and Freund43, Reference King and Mann44). The ethanol-treated animals showed a decrease in fructose content and SORD activity. This accounts for the reduced sperm motility in the ethanol-loaded groups. There were significant increases in fructose content and SORD activity on ascorbic acid supplementation, which further improved sperm quality. Abstention could not substantially increase the concentration of fructose and SORD activity, as compared with the ascorbic acid-supplemented group.
SDH is a key enzyme in the mitochondrial Kreb's cycle, which is mainly concerned with the aerobic oxidation of acetyl CoA and the generation of ATP. A decrease in SDH activity in the testes of ethanol-ingested guinea pigs indicates a reduction in aerobic oxidation, which could be the result of reduced oxygen transport to tissues(Reference Romero, Bosch-Morell and Romero45). Reduced aerobic oxidation and ATP generation in the testes could be responsible for the reduction in ATPase activity. Decreased SDH and ATPase activity with reduced fructose levels could explain the reduced sperm count and motility and the increased number of non-viable spermatozoa observed in the ethanol-administered animals. Ascorbic acid supplementation restored both SDH and ATPase activity, which accounts for the restoration of diminished sperm quality in the ascorbic acid-supplemented group. Abstention from alcohol was able to increase SDH and ATPase activity, but was less significant when compared with the ascorbic acid-supplemented group.
Conclusion
The present study demonstrates that ascorbic acid supplementation causes a reduction of alcohol-induced testicular toxicity to a greater extent than abstention. The mechanism may be by reducing oxidative stress and improving antioxidant status, which eventually change the microenvironment of testes and enhance the energy needed for motility of sperms, improve the sperm morphology and increase the testosterone levels. The increase in testosterone levels may be due to increased steroidogenic enzyme activities and elevated levels of LH and FSH of the hypothalamic–pituitary–gonadal axis. In short, therapeutic supplementation of ascorbic acid is effective in minimising the alterations produced by alcohol-induced testicular damage. Further studies are needed to complement and extrapolate the findings of the study to human subjects.
Supplementary material
To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S0007114512005739
Acknowledgements
Financial assistance in the form of a Research Fellowship in Science to Meritorious Students sponsored by UGC to R. H. is gratefully acknowledged. R. H. designed and performed the experiment, analysed the data and prepared the manuscript; P. A. A. performed the experiment and helped in drafting the manuscript; S. S. D. analysed the data; P. P., S. R., F. J. and S. K. performed the biochemical assays. M. I. was responsible for the very concept and design of the experiment and interpretation of the data. All authors read and approved the final manuscript. The authors declare that they have no conflicts of interest.